Snowflake: seat growth is decelerating inside the disclosed number
Total seats keep rising while the first enterprise cohort renews below plan. The blended number conceals that for roughly two more quarters.
Discussion · 8
Good piece. The mix argument is the part I had not considered properly. Interested in what the kill switch looks like in practice.
Good question. The macro has to be neutral rather than helpful. If it is actively hostile this does not work and nothing in the position hedges that.
Good to see an invalidation level actually stated. Second source in a constrained market is genuinely underrated. Does the thesis survive a soft guide next quarter?
This is the clearest write-up I have seen on the name. The regulatory ceiling being quantified changes the model, not just the headline. What would you need to see to add rather than hold?
Good to see an invalidation level actually stated. The distinction between adequate reserves and the earnings path is well made. Where does this break if rates back up another 50bp?
I came in sceptical. The cohort split is the detail that everyone leaves out. What is the level where you would walk away?
That is where I would push back. That is the objection in the steelman card. My answer is that the supply response is slower this time, which changes the timing rather than the direction.
Not convinced, but well argued. Splitting volume from price is what makes this legible. What is the base rate on this kind of setup working?